-
Sector Analysis
North America Cannabis Market Summary, Competitive Analysis and Forecast to 2029
Cannabis in North America industry profile provides top-line qualitative and quantitative summary information including: market size (value 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights - Cannabis refers to a group of three psychoactive plants: Cannabis sativa, Cannabis indica, and Cannabis ruderalis. Our market scope includes both recreational and medicinal uses of cannabis, which are governed by regulated operations. This...
-
Sector Analysis
Europe Cannabis Market Summary, Competitive Analysis and Forecast to 2029
Cannabis in Europe industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights - Cannabis refers to a group of three psychoactive plants: Cannabis sativa, Cannabis indica, and Cannabis ruderalis. Our market scope includes both recreational and medicinal uses of cannabis, which are governed by regulated operations....
-
Sector Analysis
Asia-Pacifc Cannabis Market Summary, Competitive Analysis and Forecast to 2029
Cannabis in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights - Cannabis refers to a group of three psychoactive plants: Cannabis sativa, Cannabis indica, and Cannabis ruderalis. Our market scope includes both recreational and medicinal uses of cannabis, which are governed by...
-
Sector Analysis
South America Cannabis Market Summary, Competitive Analysis and Forecast to 2029
Cannabis in South America industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights - Cannabis refers to a group of three psychoactive plants: Cannabis sativa, Cannabis indica, and Cannabis ruderalis. Our market scope includes both recreational and medicinal uses of cannabis, which are governed...
-
Sector Analysis
Bio/Pharmaceutical Outsourcing Report, July 2025
The Bio/Pharmaceutical Outsourcing Report is a monthly analysis of news and trends affecting pharmaceutical Contract Manufacturing Organizations (CMOs). It includes in-depth analyses of the latest business conditions, lists new outsourcing contracts, assesses the latest opportunities and threats for manufacturers, and identifies recent mergers, acquisitions, and financing among CMOs. It also updates readers on facility-level news, such as planned site openings and closures, Good Manufacturing Practice (GMP) inspections, and investments in technology and equipment.
-
Sector Analysis
CRISPR Gene Editing in Infectious Diseases: Market Overview, Pipeline Products, Clinical Trials, Challenges, Deals, Companies and Future Outlook
The report provides an overview of the potential of CRISPR-based therapeutics in the infectious disease space. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) is a precision gene-editing tool that enables targeted modification of DNA. It uses a guide RNA to direct a Cas enzyme (such as Cas9 or Cas12) to a specific genetic sequence, where it creates a cut and allows for the insertion, deletion, or correction of DNA. In infectious diseases, CRISPR may be used to directly disrupt viral...
-
Sector Analysis
Parkinson's Disease in 68-Markets: Disease Overview, Product Profiles, Patient Flow, Competitive Assessment and Sales Forecast to 2033
This report covers the 68 geographical markets and provides an Excel-based forecast model for the Parkinson's Disease market through 2033. Across the 68 markets, sales in the Parkinson's Disease market were $5.1 billion in 2023, growing to $10.1 billion in 2033. The seven major markets (US, France, Germany, Italy, Spain, UK, and Japan) represent approximately 66.0% and 69.6% of 68-market sales in 2023 and 2033, respectively.
-
Sector Analysis
Parkinson's Disease Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2033
This report covers the 7 major markets and provides an Excel-based forecast model for the Parkinson's Disease market through 2033. GlobalData estimated that the PD market was $3.4 billion across the 7MM in 2023. By the end of the forecast period in 2033, sales across these markets will reach $7.0 billion, increasing at a compound annual growth rate (CAGR) of 7.6%. The major drivers of growth in the PD market will be the launch of several pipeline products including novel...
-
Sector Analysis
Respiratory Syncytial Virus Prophylaxis in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2030
The report provides an in-depth assessment of the RSV prophylaxis market including disease overview, epidemiology, disease management, current treatment options, unmet needs and opportunities, R&D strategies, pipeline assessment, current and future players, and market outlook. RSV is an enveloped, single-stranded, negative-sense ribonucleic acid (RNA) orthopneumovirus belonging to the Pneumoviridae family. The most common clinical scenario for RSV is an upper respiratory tract infection (URTI), which is typically mild and self-limiting. However, RSV is the leading cause of lower respiratory tract...
-
Thematic Analysis
FDI Trends in North America (2025)
Canada’s FDI outlook remains rife with economic uncertainty, being intrinsically linked to the US. According to GlobalData’s FDI Database, the US constitutes approximately 45% of the 371 (announced) FDI projects in Canada’s inward FDI pipeline (from 2023 to close of Q2 2025). Prime Minister Mark Carney initially adopted a tough rhetoric, indicating a desire to renegotiate the USCMA trading agreement. Though, the current state-of-play reads that Canada has filed a WTO dispute contesting US tariff obligations, while elevated 35% tariffs...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.